US Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth

Summary

GlobalData's ""US Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth"" report is an essential source of data and analysis on the US coronary stents market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories - bare metal stents and drug eluting stents. The report identifies the key trends shaping and driving the dynamism in the US coronary stents market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the US coronary stents market.

Scope

• The report provides market size data and information on two US coronary stents market categories - bare metal stents and drug eluting stents.
• Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.
• Analysis and review of the key events and milestones that will impact the future of the US coronary stents market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
• Insightful review of key industry drivers, restraints and challenges which are likely to impact the US coronary stents market in the long run.
• In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Reasons to buy

• Develop business strategies by understanding the trends shaping and driving the US coronary stents Market.
• Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
• Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the US coronary stents market in future.
• Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• What's the next being thing in the US coronary stents technology landscape? - Identify, understand and capitalize.

Contents

• 1 Table Of Contents
• 1.1 List of Tables
• 1.2 List of Figures
• 2 Executive Summary
• 3 Coronary Stents Market Overview
  • 3.1 Introduction and Definition
    • 3.1.1 Coronary Stents
      • 3.1.1.1 Bare Metal Stents
      • 3.1.1.2 Drug Eluting Coronary Stents
  • 3.2 Market Overview
    • 3.2.1 Risk Factors for Coronary Disease
  • 3.3 Cross Category Analysis
    • 3.3.1 US Interventional Cardiology Market Cross Category Analysis (2001-2015)
  • 3.4 Competitive Landscape
  • 3.5 The US Coronary Stents Market: Trend Analysis
    • 3.5.1 Market Snapshot
    • 3.5.2 Emergence of DES - Overview
      • 3.5.2.1 Drug Eluting Stent (DES) Market: Drivers
      • 3.5.2.2 Drug Eluting Stents (DES) Market: Restraints
    • 3.5.3 Stent Coatings
    • 3.5.4 Stent Implantation Procedure - Overview
    • 3.5.5 Key End Users
    • 3.5.6 The US Coronary Stent Market: Drivers
      • 3.5.6.1 Increased obesity rates in some population groups enhances the demand for Percutaneous Coronary Intervention (PCI)
      • 3.5.6.2 Developments in Imaging Enhanced Accuracy of Implantation and Surgical Procedures
      • 3.5.6.3 The Next Generation of Hybrid Devices Could Increase Treatment Outcome and Device Applicability
    • 3.5.7 The US Coronary Stents Market: Restraints
      • 3.5.7.1 Negative promotion activities related to stents market have affected the usage of DES
      • 3.5.7.2 High price of treating cardiovascular diseases results in more economics based decision making on the part of healthcare providers
    • 3.5.8 Emerging Technologies in the US Coronary Stents Market
      • 3.5.8.1 Diamond like Carbon Coating (DLC)
      • 3.5.8.2 Advanced Drug eluting coatings
      • 3.5.8.3 Bioabsorbable Stents
      • 3.5.8.4 Platinum Enriched Stainless Steel (PERSE)
      • 3.5.8.5 Antibody coated or gene therapy stents
  • 3.6 Future Outlook and Implications: US Coronary Stents Market
• 4 Mergers & Acquisitions
  • 4.1 Mergers & Acquisitions in 2009
    • 4.1.1 Boston Scientific Acquires Labcoat
  • 4.2 Mergers & Acquisitions in 2007
    • 4.2.1 Medtronic Acquires Setagon
  • 4.3 Mergers & Acquisitions in 2006
    • 4.3.1 Abbott Laboratories Acquires Vascular Business of Guidant From Boston Scientific
• 5 Coronary Stent Pipeline Products
  • 5.1 Key Coronary Stents pipeline products
• 6 Appendix
  • 6.1 Research Methodology
  • 6.2 Coverage
  • 6.3 Secondary Research
  • 6.4 Primary Research
  • 6.5 Models
  • 6.6 Forecasts
  • 6.7 Expert Panels
  • 6.8 GlobalData Consulting
  • 6.9 Contact Us
  • 6.10 Disclaimer
• 1.1 List of Tables
  • Table 1: Coronary Stent Market, US, Overall Revenue ($ mn), Historic, 2001 - 2008
  • Table 2: Coronary Stent Market, US, Overall Revenue ($ mn), Forecast, 2008 - 2015
  • Table 3: Company Shares in the US Coronary Stents Market ($ mn) and (%), 2007
  • Table 4: Drug-Eluting Stents Comparison
  • Table 5: Coatings on Drug Eluting Stents
  • Table 6: Key Companies with Bioabsorbable Stents in Pipeline
  • Table 7: Coronary Stent Pipeline Products By Equipment Type
  • Table 8: Coronary Stent Pipeline Products By Development Stage
  • Table 9: Coronary Stent Pipeline Products By Therapy Area
• 1.2 List of Figures
  • Figure 1: Coronary Stents Market Definition, US, 2008
  • Figure 2: Segment Contribution By Type Of Coronary Stent Market (%), US, 2008
  • Figure 3: Coronary Stent Market, US, Overall Revenue ($ mn), 2001 - 2015
  • Figure 4: US Interventional Cardiology Market Cross Category Analysis (2001-2015)
  • Figure 5: Company Share in the US Coronary Stents Market (%), 2007
  • Figure 6: History of Coronary Artery Disease Prevention, US, 2008
  • Figure 7: Diagrammatic Representation of Artery Before and After Placing the Stent
  • Figure 8: Drivers and Restraints in the US Coronary Stent Market
  • Figure 9: GlobalData Methodology